# Cannabis for Inflammatory Bowel Disease

> **NCT01040910** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Meir Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Crohn's Disease
- Ulcerative Colitis

## Interventions

- **DRUG:** smoking of cannabis
- **DRUG:** smoking cigarettes with placebo

## Key facts

- **NCT ID:** NCT01040910
- **Lead sponsor:** Meir Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01040910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01040910, "Cannabis for Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01040910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*